sarsasapogenin has been researched along with Alzheimer Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Liu, P; Ren, Q; Song, S; Wang, D; Wang, S; Wang, W; Wang, Z; Yao, G; Zhang, Y | 1 |
| Ge, SL; Huang, J; Li, SL; Ma, L; Wang, R; Wu, Y; Yang, GX | 1 |
| Li, W; Liu, G; Ma, L; Sun, J; Tang, Y; Wang, R; Wu, Z; Yu, Z; Zhou, M | 1 |
| Fan, L; Shi, J; Song, C; Wang, H; Wang, J; Yang, S; Zhang, P; Zhang, R; Zhang, Y | 1 |
| Kashyap, P; Kumar, S; Muthusamy, K; Niranjan, M; Trikha, S | 1 |
| Bednarikova, Z; Gancar, M; Gazova, Z; Huang, Y; Luo, Y; Ma, L; Spodniakova, B; Tang, Y; Wang, R; Zheng, L | 1 |
| Gou, LS; Gu, PP; Huang, TT; Liu, YW; Ma, TF; Zhang, YM; Zheng, T | 1 |
| Song, SJ; Wang, SJ; Wang, W; Wang, WB; Wang, ZD; Yao, GD | 1 |
8 other study(ies) available for sarsasapogenin and Alzheimer Disease
| Article | Year |
|---|---|
Novel sarsasapogenin-triazolyl hybrids as potential anti-Alzheimer's agents: Design, synthesis and biological evaluation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anemarrhena; Animals; Apoptosis; Cell Line; Drug Design; Hippocampus; Humans; Male; Maze Learning; Mice; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Spirostans | 2018 |
Design, synthesis and biological evaluation of 3-piperazinecarboxylate sarsasapogenin derivatives as potential multifunctional anti-Alzheimer agents.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Antioxidants; Drug Design; Humans; Mice; Molecular Docking Simulation; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Piperazines; Protein Aggregates; Rats; RAW 264.7 Cells; Spirostans | 2018 |
Investigation of Anti-Alzheimer's Mechanisms of Sarsasapogenin Derivatives by Network-Based Combining Structure-Based Methods.
Topics: Alzheimer Disease; Animals; Molecular Docking Simulation; Neurodegenerative Diseases; Spirostans | 2023 |
Smilagenin induces expression and epigenetic remodeling of BDNF in alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Epigenesis, Genetic; Hippocampus; Histones; Humans; Mice; Mice, Transgenic; Neuroblastoma | 2023 |
Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Asparagus Plant; Aspartic Acid Endopeptidases; Biphenyl Compounds; Butyrylcholinesterase; Cell Survival; Electrophorus; Enzyme Inhibitors; Horses; Humans; Ligands; Monoamine Oxidase; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Picrates; Rats; Spirostans | 2020 |
Extracts from Chinese herbs with anti-amyloid and neuroprotective activities.
Topics: Abietanes; Alzheimer Disease; Amyloid beta-Peptides; Anemarrhena; Benzofurans; Cell Line; China; Humans; Neuroprotective Agents; Peptide Fragments; Plant Extracts; Salvia miltiorrhiza; Spirostans | 2021 |
Sarsasapogenin attenuates Alzheimer-like encephalopathy in diabetes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain Diseases; Cell Line; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Hippocampus; Phosphorylation; PPAR gamma; Rats; Spirostans; tau Proteins | 2021 |
Synthesis and evaluation of 26-amino acid methyl ester substituted sarsasapogenin derivatives as neuroprotective agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acids; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Esters; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Neuroprotective Agents; Spirostans | 2017 |